Publication | Closed Access

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia

Cardiovascular DiseaseAtherosclerosisMyocardial InfarctionImmunologyShort-term Risk AssessmentPathologyNovel BiomarkersCardiovascular ToxicityMedicineCardiologyAcute Myocardial InfarctionC-terminal Fragments